Ultragenyx Pharmaceutical Inc.
CIK 1515673 · last filed 2021-08-12
Ultragenyx Pharmaceutical Inc. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $43.6M of ARCT on Aug 12, 2021. Across all open-market trades the lifetime net is −$124.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.76M
1
3
-$124.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARCT | Director | 1,400,000 | $6.97 | $9.76M | -$124.28M | 3 | 2021-08-12 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-12 | ARCT | Sell (S) | −800,000 | -$43.63M | EDGAR |
| 2020-12-10 | ARCT | Sell (S) | −800,000 | -$80.65M | EDGAR |
| 2020-05-22 | ARCT | Exer (M) | +600,000 | $9.60M | EDGAR |